For example, tumor-derived exosomes modified with specific ncRNAs can target IL-6, IL-17, IL-1B, TGFβ, IFN-γ, and TLR4 to induce dendritic cell maturation and to enhance its immune-stimulating capacity (121). The gene discussed is IL6; the disease is neoplasm.